$1.13 Earnings Per Share Expected for Stericycle Inc (SRCL) This Quarter

Share on StockTwits

Analysts expect that Stericycle Inc (NASDAQ:SRCL) will post earnings of $1.13 per share for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Stericycle’s earnings. The lowest EPS estimate is $1.09 and the highest is $1.15. Stericycle posted earnings per share of $1.15 during the same quarter last year, which would indicate a negative year-over-year growth rate of 1.7%. The company is scheduled to report its next quarterly earnings report on Thursday, August 2nd.

According to Zacks, analysts expect that Stericycle will report full-year earnings of $4.63 per share for the current financial year, with EPS estimates ranging from $4.48 to $4.70. For the next fiscal year, analysts forecast that the firm will report earnings of $4.78 per share, with EPS estimates ranging from $4.63 to $4.96. Zacks’ EPS calculations are a mean average based on a survey of analysts that that provide coverage for Stericycle.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, May 3rd. The business services provider reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.16. Stericycle had a return on equity of 14.14% and a net margin of 0.19%. The company had revenue of $895.00 million for the quarter, compared to the consensus estimate of $880.48 million. During the same period in the previous year, the business earned $1.09 EPS. Stericycle’s revenue for the quarter was up .3% compared to the same quarter last year.

Several equities research analysts have issued reports on the company. Barrington Research restated a “buy” rating on shares of Stericycle in a report on Friday, June 1st. BidaskClub lowered Stericycle from a “buy” rating to a “hold” rating in a research report on Friday, May 25th. BMO Capital Markets lifted their target price on Stericycle from $64.00 to $67.00 and gave the stock a “market perform” rating in a research report on Friday, May 4th. ValuEngine lowered Stericycle from a “sell” rating to a “strong sell” rating in a research report on Wednesday, May 2nd. Finally, Royal Bank of Canada decreased their target price on Stericycle from $75.00 to $61.00 and set an “underperform” rating for the company in a research report on Thursday, February 22nd. Two research analysts have rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $78.63.

In related news, Director Thomas D. Brown sold 13,210 shares of the business’s stock in a transaction that occurred on Wednesday, May 16th. The stock was sold at an average price of $63.37, for a total transaction of $837,117.70. Following the completion of the transaction, the director now owns 14,705 shares in the company, valued at approximately $931,855.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Charles A. Alutto sold 13,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 29th. The shares were sold at an average price of $62.68, for a total value of $814,840.00. Following the transaction, the chief executive officer now owns 17,026 shares of the company’s stock, valued at approximately $1,067,189.68. The disclosure for this sale can be found here. In the last quarter, insiders sold 46,834 shares of company stock valued at $2,966,543. Insiders own 3.50% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in the stock. California State Teachers Retirement System boosted its position in Stericycle by 0.6% during the 4th quarter. California State Teachers Retirement System now owns 138,949 shares of the business services provider’s stock valued at $9,447,000 after purchasing an additional 815 shares during the period. Massmutual Trust Co. FSB ADV boosted its position in Stericycle by 27.7% during the 1st quarter. Massmutual Trust Co. FSB ADV now owns 3,904 shares of the business services provider’s stock valued at $229,000 after purchasing an additional 847 shares during the period. Glenview Trust Co boosted its position in Stericycle by 9.6% during the 1st quarter. Glenview Trust Co now owns 10,163 shares of the business services provider’s stock worth $594,000 after acquiring an additional 886 shares during the period. Noesis Capital Mangement Corp boosted its position in Stericycle by 1.2% during the 1st quarter. Noesis Capital Mangement Corp now owns 73,215 shares of the business services provider’s stock worth $4,285,000 after acquiring an additional 890 shares during the period. Finally, Rhumbline Advisers boosted its position in Stericycle by 0.6% during the 1st quarter. Rhumbline Advisers now owns 143,833 shares of the business services provider’s stock worth $8,419,000 after acquiring an additional 912 shares during the period. Institutional investors and hedge funds own 97.50% of the company’s stock.

SRCL stock traded up $1.12 during midday trading on Tuesday, hitting $64.29. 13,033 shares of the company’s stock were exchanged, compared to its average volume of 602,794. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.88. Stericycle has a 12-month low of $56.64 and a 12-month high of $83.25. The company has a market capitalization of $5.38 billion, a PE ratio of 14.79, a P/E/G ratio of 1.41 and a beta of 0.41.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.

Get a free copy of the Zacks research report on Stericycle (SRCL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply